Lista de obras - György Bodoky - Dominio Público Uruguay

A phase II open-label randomized study to assess the efficacy and safety of selumetinib (AZD6244 [ARRY-142886]) versus capecitabine in patients with advanced or metastatic pancreatic cancer who have failed first-line gemcitabine therapy

artículo científico publicado en 2011

An up-to-date method of early postoperative enteral feeding

artículo científico publicado en 1987

Association of progression-free survival with patient-reported outcomes and survival: results from a randomised phase 3 trial of panitumumab.

artículo científico publicado en 2007

Blood supply of metastatic hepatic tumors: suggestions for improved delivery of chemotherapeutic agents

scientific article published on 01 June 1998

CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial

artículo científico publicado en 2008

Cancer epidemiology in Central, South and Eastern European countries.

artículo científico publicado en 2011

Carcinoid tumors

artículo científico publicado en 2010

Cationic liposomal paclitaxel plus gemcitabine or gemcitabine alone in patients with advanced pancreatic cancer: a randomized controlled phase II trial

artículo científico publicado en 2011

Cediranib with mFOLFOX6 versus bevacizumab with mFOLFOX6 as first-line treatment for patients with advanced colorectal cancer: a double-blind, randomized phase III study (HORIZON III).

artículo científico publicado en 2012

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

artículo científico publicado en 2009

Clinical Benefit and Health-Related Quality of Life Assessment in Patients Treated with Cisplatin/S-1 Versus Cisplatin/5-FU: Secondary End Point Results From the First-Line Advanced Gastric Cancer Study (FLAGS).

artículo científico publicado en 2015

Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial--SAKK 44/00-CECOG/PAN.1.3.001.

artículo científico publicado en 2008

Clinical benefit response in pancreatic cancer trials revisited

artículo científico publicado en 2014

Combination of cisplatin/S-1 in the treatment of patients with advanced gastric or gastroesophageal adenocarcinoma: Results of noninferiority and safety analyses compared with cisplatin/5-fluorouracil in the First-Line Advanced Gastric Cancer Study ⬇️

artículo científico publicado el 27 de julio de 2013

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

artículo científico publicado en 2012

ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology.

artículo científico publicado en 2006

Effect of enteral nutrition on exocrine pancreatic function ⬇️

artículo científico publicado el 1 de enero de 1991

Effect of imatinib treatment of gastrointestinal stromal tumors

artículo científico publicado en 2003

Effects of different types of isocaloric parenteral nutrients on food intake and metabolic concomitants.

artículo científico publicado en 1995

Effects of fasting, intermittent feeding, or continuous parenteral nutrition on rat liver and brain energy metabolism as assessed by 31P-NMR.

artículo científico publicado en 1995

Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy

artículo científico publicado en 2010

Experience with everolimus therapy for patients with metastatic renal cancer in Hungary

artículo científico publicado en 2014

Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer

artículo científico publicado en 2014

First Hungarian experience with pazopanib therapy for patients with metastatic renal cancer

artículo científico publicado en 2013

Ileus of Meckel's diverticulum caused by paramatritis

artículo científico publicado en 1972

Neoadjuvant chemoradiotherapy with or without panitumumab in patients with wild-type KRAS, locally advanced rectal cancer (LARC): a randomized, multicenter, phase II trial SAKK 41/07.

artículo científico publicado en 2012

Nocturnal cyclic versus continuous total parenteral nutrition: food intake and feeding pattern in rats

artículo científico publicado en 1992

ON ACUTE PNEUMO-CHOLECYSTITIS.

artículo científico publicado en 1963

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

artículo científico publicado en 2013

Phase II randomized, double-blind, placebo-controlled study of AMG 386 (trebananib) in combination with cisplatin and capecitabine in patients with metastatic gastro-oesophageal cancer ⬇️

artículo científico publicado el 28 de octubre de 2012

Pretreatment MicroRNA Level and Outcome in Sorafenib-treated Hepatocellular Carcinoma.

artículo científico publicado en 2014

Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.

artículo científico publicado en 2009

Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3.

artículo científico publicado en 2009

Randomized, double-blind, active-controlled trial of every-3-week darbepoetin alfa for the treatment of chemotherapy-induced anemia

artículo científico publicado en 2006

Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study

artículo científico publicado en 2010

Randomized, placebo-controlled, phase III study of first-line oxaliplatin-based chemotherapy plus PTK787/ZK 222584, an oral vascular endothelial growth factor receptor inhibitor, in patients with metastatic colorectal adenocarcinoma.

scientific article published on 04 April 2011

Rectal cancer therapy: decision making on basis of quality of life?

artículo científico publicado en 2004

State of artificial nutrition in Hungary: standpoint and methodologic recommendations

artículo científico publicado en 1999

Status report on the chemotherapy of ovarian cancer at special cancer centers in Hungary (2002-2003)

artículo científico publicado en 2004

The activated targets of mTOR signaling pathway are characteristic for PDGFRA mutant and wild-type rather than KIT mutant GISTs

artículo científico publicado en 2011

The comparative effects of abrupt vs. stepwise discontinuation of TPN in rats

scientific article published on 01 September 1992

The effect of jejunal nutrition on pancreatic exocrine function

artículo científico publicado en 1992

The method of early postoperative alimentation by needle-catheter jejunostomy

artículo científico publicado en 1989

The results of ovarian cancer therapy in the Hungarian Centers in 2002-2003

artículo científico publicado en 2006

Tricellulin expression in normal and neoplastic human pancreas ⬇️

artículo científico publicado el 6 de marzo de 2012

Tumor response and symptom palliation from RAINBOW, a phase 3 trial of ramucirumab plus paclitaxel in previously treated advanced gastric cancer

artículo científico publicado en 2020

[Cancer survivors--quality of life in Hungarian cancer patients. A retrospective study]

artículo científico publicado en 2011

[Data on steroid therapy of hypotensive shock].

artículo científico publicado en 1962

[Diagnostic problems of intra-abdominal abscesses]

scientific article published on 01 May 1972

[Difficulties of artificial nutrition in short bowel syndrome]

artículo científico publicado en 1999

[Effect of KRAS mutation status on the efficiency of Avastin therapy of colorectal cancer]

artículo científico publicado en 2011

[Experience with early postoperative feeding through a needle-catheter jejunostomy]

artículo científico publicado en 1986

[Gartner's cyst in an inguinal hernia]

artículo científico publicado en 1974

[Histomorphologic and histochemical studies of preoperatively irradiated breast tumors]

scientific article published on 01 January 1965

[Low-dose leucovorin and interferon-alpha as modulators of 5-fluorouracil for adjuvant chemotherapy of colorectal cancer]

artículo científico publicado en 1998

[OUR EXPERIENCES WITH LIVER SCINTILLOGRAPHY: RADIOISOTOPE SCANNING OF THE LIVER.]

scientific article published on 01 January 1964

[Pharmacologic therapy for neuroendocrine tumours]

scientific article published on 01 March 2011

[Role of angiogenesis inhibitors in the treatment of colorectal cancer]

artículo científico publicado en 2007

[Siderofibrosis lienis]

artículo científico publicado en 1959

[The effect of early postoperative jejunal feeding on the exocrine function of the pancreas]

artículo científico publicado en 1990

[The effect of two different methods of jejunal feeding on pancreatic function]

scientific article published on 01 December 1991

[Therapy of secondary complications of varicose veins]

artículo científico publicado en 1958

Lista de obras de György Bodoky

A phase II open-label randomized study to assess the efficacy and safety of selumetinib (AZD6244 [ARRY-142886]) versus capecitabine in patients with advanced or metastatic pancreatic cancer who have failed first-line gemcitabine therapy

An up-to-date method of early postoperative enteral feeding

Association of progression-free survival with patient-reported outcomes and survival: results from a randomised phase 3 trial of panitumumab.

Blood supply of metastatic hepatic tumors: suggestions for improved delivery of chemotherapeutic agents

CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial

Cancer epidemiology in Central, South and Eastern European countries.

Carcinoid tumors

Cationic liposomal paclitaxel plus gemcitabine or gemcitabine alone in patients with advanced pancreatic cancer: a randomized controlled phase II trial

Cediranib with mFOLFOX6 versus bevacizumab with mFOLFOX6 as first-line treatment for patients with advanced colorectal cancer: a double-blind, randomized phase III study (HORIZON III).

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

Clinical Benefit and Health-Related Quality of Life Assessment in Patients Treated with Cisplatin/S-1 Versus Cisplatin/5-FU: Secondary End Point Results From the First-Line Advanced Gastric Cancer Study (FLAGS).

Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial--SAKK 44/00-CECOG/PAN.1.3.001.

Clinical benefit response in pancreatic cancer trials revisited

Combination of cisplatin/S-1 in the treatment of patients with advanced gastric or gastroesophageal adenocarcinoma: Results of noninferiority and safety analyses compared with cisplatin/5-fluorouracil in the First-Line Advanced Gastric Cancer Study ⬇️

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology.

Effect of enteral nutrition on exocrine pancreatic function ⬇️

Effect of imatinib treatment of gastrointestinal stromal tumors

Effects of different types of isocaloric parenteral nutrients on food intake and metabolic concomitants.

Effects of fasting, intermittent feeding, or continuous parenteral nutrition on rat liver and brain energy metabolism as assessed by 31P-NMR.

Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy

Experience with everolimus therapy for patients with metastatic renal cancer in Hungary

Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer

First Hungarian experience with pazopanib therapy for patients with metastatic renal cancer

Ileus of Meckel's diverticulum caused by paramatritis

Neoadjuvant chemoradiotherapy with or without panitumumab in patients with wild-type KRAS, locally advanced rectal cancer (LARC): a randomized, multicenter, phase II trial SAKK 41/07.

Nocturnal cyclic versus continuous total parenteral nutrition: food intake and feeding pattern in rats

ON ACUTE PNEUMO-CHOLECYSTITIS.

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

Phase II randomized, double-blind, placebo-controlled study of AMG 386 (trebananib) in combination with cisplatin and capecitabine in patients with metastatic gastro-oesophageal cancer ⬇️

Pretreatment MicroRNA Level and Outcome in Sorafenib-treated Hepatocellular Carcinoma.

Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.

Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3.

Randomized, double-blind, active-controlled trial of every-3-week darbepoetin alfa for the treatment of chemotherapy-induced anemia

Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study

Randomized, placebo-controlled, phase III study of first-line oxaliplatin-based chemotherapy plus PTK787/ZK 222584, an oral vascular endothelial growth factor receptor inhibitor, in patients with metastatic colorectal adenocarcinoma.

Rectal cancer therapy: decision making on basis of quality of life?

State of artificial nutrition in Hungary: standpoint and methodologic recommendations

Status report on the chemotherapy of ovarian cancer at special cancer centers in Hungary (2002-2003)

The activated targets of mTOR signaling pathway are characteristic for PDGFRA mutant and wild-type rather than KIT mutant GISTs

The comparative effects of abrupt vs. stepwise discontinuation of TPN in rats

The effect of jejunal nutrition on pancreatic exocrine function

The method of early postoperative alimentation by needle-catheter jejunostomy

The results of ovarian cancer therapy in the Hungarian Centers in 2002-2003

Tricellulin expression in normal and neoplastic human pancreas ⬇️

Tumor response and symptom palliation from RAINBOW, a phase 3 trial of ramucirumab plus paclitaxel in previously treated advanced gastric cancer

[Cancer survivors--quality of life in Hungarian cancer patients. A retrospective study]

[Data on steroid therapy of hypotensive shock].

[Diagnostic problems of intra-abdominal abscesses]

[Difficulties of artificial nutrition in short bowel syndrome]

[Effect of KRAS mutation status on the efficiency of Avastin therapy of colorectal cancer]

[Experience with early postoperative feeding through a needle-catheter jejunostomy]

[Gartner's cyst in an inguinal hernia]

[Histomorphologic and histochemical studies of preoperatively irradiated breast tumors]

[Low-dose leucovorin and interferon-alpha as modulators of 5-fluorouracil for adjuvant chemotherapy of colorectal cancer]

[OUR EXPERIENCES WITH LIVER SCINTILLOGRAPHY: RADIOISOTOPE SCANNING OF THE LIVER.]

[Pharmacologic therapy for neuroendocrine tumours]

[Role of angiogenesis inhibitors in the treatment of colorectal cancer]

[Siderofibrosis lienis]

[The effect of early postoperative jejunal feeding on the exocrine function of the pancreas]

[The effect of two different methods of jejunal feeding on pancreatic function]

[Therapy of secondary complications of varicose veins]